News - TBVI

In Uncategorized Posted February 6, 2020

Les Diablerets Switzerland, the TBVI meeting “Accelerating the TB vaccine pipeline – towards Horizon Europe”

From 27th to 29th January 2020 in Les Diablerets Switzerland, the TBVI meeting “Accelerating the TB vaccine pipeline – towards Horizon Europe” brought together 120 scientists and policy makers [...]

By Marit Holleman

In Uncategorized Posted January 31, 2020

6th Global Forum on TB Vaccines 2021

The 6th Global Forum on TB Vaccines will take place from 20 – 22 April 2021 in France at the Centre Pierre Baudis in Toulouse. Please read the announcement of the Global Forum 2021.

By Cora Agterdenbosch

In Uncategorized Posted January 23, 2020

Programme of the TBVI meeting in Les Diablerets – Switzerland

The final programme of the TBVI meeting “Accelerating the TB vaccine pipeline – towards Horizon Europe” is available. The TBVI meeting will be held in Les Diablerets, Switzerland from [...]

By Marit Holleman

In Uncategorized Posted January 23, 2020

Workshop “Maintaining European scientific excellence and global leadership in EU funded collaborative TB Vaccine research and innovation” – Impact of three H2020 projects, TBVAC2020, EMI-TB and STriTuVaD, on the global TB vaccine pipeline (8 October 2019, Brussels)

Thanks to H2020 investments substantial progress has been made in the innovation and development of vaccines against TB. This is shown by the promising results of three H2020-funded TB vaccine [...]

By Marit Holleman

In Uncategorized Posted November 15, 2019

Publication: “Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations”

The publication preferred product characteristics (PPC) for therapeutic TB vaccines provides guidance to scientists, funding agencies, public and private sector organizations developing such [...]